UniQure’s hemophilia B gene therapy achieves 31% FIX activity

UniQure’s hemophilia B gene therapy achieves 31% FIX activity

Submitted by admin on November 15, 2018 - 9:51am
Source: 
Fierce Biotech
News Tags: 
uniQure
hemophilia B
gene therapy
FIX-Padula
Headline: 
UniQure’s hemophilia B gene therapy achieves 31% FIX activity
snippet: 

UniQure has posted eagerly-anticipated data on the modified hemophilia B gene therapy it plans to take into phase 3.

Do Not Allow Advertisers to Use My Personal information